{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T18:59:05Z","timestamp":1780772345431,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-026-00614-0","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T18:13:40Z","timestamp":1780769620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ALKBH5 promotes the progression of cisplatin-resistant oral squamous cell carcinoma by regulating FOXA1 expression via m6A RNA methylation"],"prefix":"10.1007","volume":"34","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Feng","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"4","key":"614_CR1","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.3390\/curroncol30040283","volume":"30","author":"M Badwelan","year":"2023","unstructured":"Badwelan M, et al. Oral Squamous Cell Carcinoma and Concomitant Primary Tumors, What Do We Know? A Review of the Literature. Curr Oncol. 2023;30(4):3721\u201334.","journal-title":"Curr Oncol"},{"issue":"1","key":"614_CR2","doi-asserted-by":"publisher","first-page":"15945","DOI":"10.1038\/s41598-025-00703-1","volume":"15","author":"KY Su","year":"2025","unstructured":"Su KY, et al. Autophagy and extracellular vesicles mediate cisplatin resistance in oral squamous cell carcinoma with LC3B-II as a potential non-invasive biomarker. Sci Rep. 2025;15(1):15945.","journal-title":"Sci Rep"},{"issue":"3","key":"614_CR3","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"614_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13062-025-00622-1","volume":"20","author":"X Zhang","year":"2025","unstructured":"Zhang X, et al. E3 ligase HERC5-catalyzed UGDH isgylation promotes SNAI1-mediated tumor metastasis and cisplatin resistance in oral squamous cell carcinoma. Biol Direct. 2025;20(1):27.","journal-title":"Biol Direct"},{"issue":"1","key":"614_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s40168-024-01907-9","volume":"12","author":"J Zhou","year":"2024","unstructured":"Zhou J, et al. Tumor-colonized Streptococcus mutans metabolically reprograms tumor microenvironment and promotes oral squamous cell carcinoma. Microbiome. 2024;12(1):193.","journal-title":"Microbiome"},{"issue":"5","key":"614_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3892\/etm.2023.11924","volume":"25","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Wang X, Chen D. Proteasome inhibitor MG132 enhances the sensitivity of human OSCC cells to cisplatin via a ROS\/DNA damage\/p53 axis. Exp Ther Med. 2023;25(5):224.","journal-title":"Exp Ther Med"},{"issue":"20","key":"614_CR7","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.18632\/oncotarget.27557","volume":"11","author":"B Kulkarni","year":"2020","unstructured":"Kulkarni B, et al. Exosome-mediated delivery of miR-30a sensitize cisplatin-resistant variant of oral squamous carcinoma cells via modulating Beclin1 and Bcl2. Oncotarget. 2020;11(20):1832\u201345.","journal-title":"Oncotarget"},{"key":"614_CR8","doi-asserted-by":"publisher","first-page":"1485174","DOI":"10.3389\/fimmu.2024.1485174","volume":"15","author":"C Li","year":"2024","unstructured":"Li C, Dong X, Li B. Tumor microenvironment in oral squamous cell carcinoma. Front Immunol. 2024;15:1485174.","journal-title":"Front Immunol"},{"key":"614_CR9","doi-asserted-by":"crossref","unstructured":"Sasahira T, Kirita T. Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma. Int J Mol Sci. 2018;19(8):2413.","DOI":"10.3390\/ijms19082413"},{"issue":"1","key":"614_CR10","doi-asserted-by":"publisher","first-page":"e22652","DOI":"10.1096\/fj.202101506RRR","volume":"37","author":"I Warren","year":"2023","unstructured":"Warren I, et al. FOXA1\/2 depletion drives global reprogramming of differentiation state and metabolism in a human liver cell line and inhibits differentiation of human stem cell-derived hepatic progenitor cells. FASEB J. 2023;37(1):e22652.","journal-title":"FASEB J"},{"key":"614_CR11","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.2147\/OTT.S252890","volume":"13","author":"Z Yuan","year":"2020","unstructured":"Yuan Z, et al. FOXA1 Promotes Cell Proliferation and Suppresses Apoptosis in HCC by Directly Regulating miR-212-3p\/FOXA1\/AGR2 Signaling Pathway. Onco Targets Ther. 2020;13:5231\u201340.","journal-title":"Onco Targets Ther"},{"key":"614_CR12","first-page":"111911","volume":"831","author":"X Zhang","year":"2025","unstructured":"Zhang X, et al. A novel mechanism in driving non-small cell lung cancer progression: The METTL3\/FOXA1\/PTK2 cascade. Mutat Res. 2025;831:111911.","journal-title":"Mutat Res"},{"issue":"2","key":"614_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/10985549.2024.2307574","volume":"44","author":"KR Pasterczyk","year":"2024","unstructured":"Pasterczyk KR, et al. Staufen1 Represses the FOXA1-Regulated Transcriptome by Destabilizing FOXA1 mRNA in Colorectal Cancer Cells. Mol Cell Biol. 2024;44(2):43\u201356.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"614_CR14","doi-asserted-by":"publisher","first-page":"e70087","DOI":"10.1002\/ddr.70087","volume":"86","author":"J Yang","year":"2025","unstructured":"Yang J, et al. FOXA1 Targets NEK2 to Mediate Cisplatin Resistance in Lung Adenocarcinoma Cells by Activating DNA Damage Repair. Drug Dev Res. 2025;86(2):e70087.","journal-title":"Drug Dev Res"},{"issue":"9","key":"614_CR15","doi-asserted-by":"publisher","first-page":"12421","DOI":"10.1007\/s00210-025-04041-x","volume":"398","author":"J Bai","year":"2025","unstructured":"Bai J, Bai J, Zhang H. FOXA1-mediated transcription of MFAP2 facilitates cell growth, metastasis and cisplatin resistance in uterine corpus endometrial carcinoma. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(9):12421\u201331.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"614_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2019.0347","volume":"17","author":"Z Liang","year":"2020","unstructured":"Liang Z, et al. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer. Cancer Biol Med. 2020;17(1):9\u201319.","journal-title":"Cancer Biol Med"},{"issue":"6","key":"614_CR17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","volume":"28","author":"Y Yang","year":"2018","unstructured":"Yang Y, et al. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28(6):616\u201324.","journal-title":"Cell Res"},{"issue":"1","key":"614_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s13046-021-02088-1","volume":"40","author":"S Nie","year":"2021","unstructured":"Nie S, et al. ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer. J Exp Clin Cancer Res. 2021;40(1):284.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"614_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13045-022-01224-4","volume":"15","author":"J Qu","year":"2022","unstructured":"Qu J, et al. RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential. J Hematol Oncol. 2022;15(1):8.","journal-title":"J Hematol Oncol"},{"key":"614_CR20","doi-asserted-by":"crossref","unstructured":"Shriwas O et al. DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m(6)A-demethylation of FOXM1 and NANOG. Apoptosis. 2020;25(3\u20134):233\u201346.","DOI":"10.1007\/s10495-020-01591-8"},{"issue":"11","key":"614_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrc2223","volume":"7","author":"SS Myatt","year":"2007","unstructured":"Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 2007;7(11):847\u201359.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"614_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41420-025-02595-6","volume":"11","author":"Y Qin","year":"2025","unstructured":"Qin Y, et al. Targeting the FOXA1\/BMI1 axis to overcome chemoresistance and suppress tumor progression in nasopharyngeal carcinoma. Cell Death Discov. 2025;11(1):311.","journal-title":"Cell Death Discov"},{"key":"614_CR23","doi-asserted-by":"crossref","unstructured":"Wang Z et al. FOXA1 Leads to Aberrant Expression of SIX4 Affecting Cervical Cancer Cell Growth and Chemoresistance. Anal Cell Pathol (Amst), 2022. 2022: p. 9675466.","DOI":"10.1155\/2022\/9675466"},{"issue":"6","key":"614_CR24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tig.2011.03.003","volume":"27","author":"BA Benayoun","year":"2011","unstructured":"Benayoun BA, Caburet S, Veitia RA. Forkhead transcription factors: key players in health and disease. Trends Genet. 2011;27(6):224\u201332.","journal-title":"Trends Genet"},{"issue":"1","key":"614_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1600-0714.2012.01170.x","volume":"42","author":"AJ Dalley","year":"2013","unstructured":"Dalley AJ, et al. Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75 NTR in malignancy. J Oral Pathol Med. 2013;42(1):37\u201346.","journal-title":"J Oral Pathol Med"},{"issue":"10","key":"614_CR26","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20(10):608\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"614_CR27","doi-asserted-by":"publisher","first-page":"106230","DOI":"10.1016\/j.archoralbio.2025.106230","volume":"175","author":"Y Liu","year":"2025","unstructured":"Liu Y, et al. Corrigendum to m6A-related genes ALKBH5 and RBMX as prognostic and progression biomarkers in Chinese oral squamous cell carcinoma patients [Archives of Oral Biology 170 (2024) 106149]. Arch Oral Biol. 2025;175:106230.","journal-title":"Arch Oral Biol"},{"issue":"3","key":"614_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.21037\/atm-25-7","volume":"13","author":"MC Drigeard Desgarnier","year":"2025","unstructured":"Drigeard Desgarnier MC, et al. The 6-methyladenine erasers ALKBH5 and FTO influence chemotherapy efficiency in bladder cancer cell lines. Ann Transl Med. 2025;13(3):26.","journal-title":"Ann Transl Med"},{"key":"614_CR29","doi-asserted-by":"crossref","unstructured":"Yu F et al. KRAS mutants confer platinum resistance by regulating ALKBH5 posttranslational modifications in lung cancer. J Clin Invest. 2025;135(6):e185149.","DOI":"10.1172\/JCI185149"},{"key":"614_CR30","doi-asserted-by":"publisher","first-page":"102993","DOI":"10.1016\/j.redox.2023.102993","volume":"69","author":"X Liu","year":"2024","unstructured":"Liu X, et al. M(6)A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer. Redox Biol. 2024;69:102993.","journal-title":"Redox Biol"},{"issue":"1","key":"614_CR31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6(1):74.","journal-title":"Signal Transduct Target Ther"},{"key":"614_CR32","doi-asserted-by":"publisher","first-page":"12626","DOI":"10.1038\/ncomms12626","volume":"7","author":"H Du","year":"2016","unstructured":"Du H, et al. YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex. Nat Commun. 2016;7:12626.","journal-title":"Nat Commun"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00614-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-026-00614-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00614-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T18:13:43Z","timestamp":1780769623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-026-00614-0"}},"subtitle":["Funding"],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["614"],"URL":"https:\/\/doi.org\/10.1007\/s40199-026-00614-0","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}